Cargando…
COVID-19-related myocarditis and cholinergic anti-inflammatory pathways
Coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2, is currently in a pandemic outbreak and has become a global health issue. In addition to the primarily involvement of the respiratory system, myocarditis is considered an important and fatal lesion in pat...
Autores principales: | Liu, Weike, Liu, Zhendong, Li, Yue-Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Cardiology. Publishing services by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7722500/ https://www.ncbi.nlm.nih.gov/pubmed/33301863 http://dx.doi.org/10.1016/j.hjc.2020.12.004 |
Ejemplares similares
-
Protective Role of the Cholinergic Anti-Inflammatory Pathway in a Mouse Model of Viral Myocarditis
por: Cheng, Zheng, et al.
Publicado: (2014) -
Right Cervical Vagotomy Aggravates Viral Myocarditis in Mice Via the Cholinergic Anti-inflammatory Pathway
por: Li-Sha, Ge, et al.
Publicado: (2017) -
Cholinergic anti-inflammatory pathway and COVID-19
por: Mehranfard, Danial, et al.
Publicado: (2022) -
The cholinergic anti-inflammatory pathway ameliorates acute viral myocarditis in mice by regulating CD4(+) T cell differentiation
por: De-Pu, Zhou, et al.
Publicado: (2018) -
Cholinergic Anti-Inflammatory Pathway and the Liver
por: Hajiasgharzadeh, Khalil, et al.
Publicado: (2017)